The Lifetime Achievement Award honors an individual who has demonstrated exceptional dedication and made
significant contributions to the advancement of cell and gene therapy over their career. This award recognizes
enduring commitment to innovation, leadership, and progress in the field.

Eligibility:
• Candidates must be an individual
• Candidates must have a minimum of 20 years’ service to the cell and gene therapy sector.
• Candidates must have made substantial contributions to the field through research, leadership, or public
service over many years

The Young Scientist Award is an annual accolade celebrating outstanding research contributions within the field of
cell and gene therapy. This prestigious award recognizes emerging scientists who demonstrate innovation,
excellence, and impact in their research endeavours.

Nominations
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be an Individual
• Candidates must have 3-7 years of professional experience post-university.
• Candidates must be under 37 years of age as of January 1st in the year of award consideration.
• Affiliation: Candidates must be affiliated to an academic institution
• Sector Involvement: Candidates must be actively engaged in cell or gene therapy research.

Inspired by Simon Ellison’s fervent advocacy for supply chain innovation and education, the Simon Ellison Supply
Chain Innovation Award honors distinguished individuals and organizations dedicated to advancing supply chain
management. This award recognizes those who have made significant contributions to supply chain innovation,
emphasizing its crucial role in improving patient outcomes.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates can be either an individual, team or organization
• Candidates must have a minimum of 4 years of experience in supply chain or logistics roles.
• Candidates must be able to demonstrate passion for supply chain innovation, for the benefit of patient
care.
• Affiliation: No requirement
• Sector Involvement: Candidates must be directly involved in supply chain or logistics roles

The ‘Women in Advanced Therapies’ award is in recognition of an individual or organisation that has initiated a call to action to remove barriers and improve and support a diverse working culture across all levels of the Advanced Therapies sector. This award is not limited to women but is inclusive of all people who have made a significant positive impact on the work life of women.

Initiatives could include, but are not limited to:

• Initiatives to ensure equality of opportunity for all from graduate to board level
• Initiatives aimed at developing women’s leadership potential, including mentor programs, women’s networks and return-to-work programs
• Initiatives showing commitment to inclusion of gender specific considerations (such as paternity, maternity and adoption initiatives, menopause considerations and flexible working)
• Improvement to employee diversity over the past 24 months

The Technology Distributor of the Year Award celebrates exceptional contributions to the field of cell & gene
therapy through technological innovation. This accolade is awarded to organizations or individuals who have
significantly advanced their industry by effectively implementing and utilizing new technologies.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be an organization or academic institution
• Candidates must have implemented significant technological improvements in real-life situations.
• Candidates must demonstrate a proven track record of successful technology implementation and
results.
• Candidates must provide testimonials or case studies that showcase the impact of their technological
advancements.
• Affiliation: Organization or academic institution
• Sector Involvement: Must be directly involved in technological advancements within cell & gene therapy

The CMO/CDMO of the Year Award honors outstanding contract manufacturing organizations (CMOs) and contract
development and manufacturing organizations (CDMOs) for their exemplary contributions to cell & gene therapy
manufacturing. This award recognizes organizations that showcase exceptional quality, innovation, and
performance.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be an organization
• Candidates must have an active manufacturer site producing cell or gene therapies
• Candidates must have introduced a revolutionary biologics platform that significantly reduces the time
and cost of drug development for their clients.
• Affiliation: CMO or CDMO
• Sector Involvement: Must be involved in active cell or gene therapy manufacturing

The Cell Therapy Innovator of the Year Award celebrates individuals, teams, or organizations that have made
significant strides in advancing cell therapy. This award acknowledges the groundbreaking contributions that
propel the field forward, emphasizing innovation and scientific excellence.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be a team or organization
• Candidates must be able to provide evidence of clinical trial data that supports significant advancements
in the field of cell therapy.
• Affiliation: Cell therapy company
• Sector Involvement: Must be involved in the development or enhancement of cell therapies.

The Gene Therapy Innovator of the Year Award honors individuals, teams, or organizations that have demonstrated
outstanding contributions to the advancement of gene therapy. This award is dedicated to recognizing those who
have pioneered developments and achieved significant breakthroughs in this vital medical field.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies
Eligibility:
• Candidates must be a team or organization
• Candidates must be able to provide evidence of clinical trial data that supports significant advancements
in the field of gene therapy.
• Affiliation: Gene therapy company
• Sector Involvement: Must be involved in the development or enhancement of gene therapies.

SPONSORED BY

The Start-up of the Year Award honors new and emerging companies within the cell & gene therapy industry that
have shown exceptional entrepreneurial spirit, innovation, and potential for future success. This award recognizes
start-ups that are poised to significantly disrupt industry norms through groundbreaking products, services, or
technologies.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be an organization
• Candidates must have been operational for less than five years and employ fewer than 10 individuals.
• Candidates must provide evidence of a new product, service, or technology that has the potential to
significantly alter or improve current industry practices.
• Affiliation: No requirement
• Sector Involvement: Must be a start-up within the cell & gene therapy industry

SPONSORED BY

The Patient Advocacy Award recognizes individuals, teams, or organizations that have made significant
contributions to advocating for patient rights, enhancing patient care, and promoting patient-centred healthcare
practices in the field of cell & gene therapy. This award celebrates those who prioritize patient welfare and
actively work to transform patient experiences and outcomes.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies

Eligibility:
• Candidates must be an individual, team, or organization
• Candidates must demonstrate measurable improvements in patient care or patient outcomes as a result
of their advocacy efforts.
• Candidates must show innovative approaches to advocacy, such as leveraging technology for patient
education, developing new platforms for patient engagement, or creating novel programs tailored to
specific patient needs.
• Affiliation: Patient advocacy organization
• Sector Involvement: Must be engaged in advocacy within the cell & gene therapy sector.

SPONSORED BY

The Leadership & Professional Development Award recognizes a forward-thinking cell and gene therapy firm that
is committed to developing future leaders. This award honors organizations that effectively integrate their
company goals with a leadership development program, both internally and externally, and have created impactful
programs that significantly enhance leadership qualities among their team members.

Nominations:
• Nominations can be submitted by anyone working within cell and gene therapies.

Eligibility:
• Candidates must be an organization
• Candidates must demonstrate a clear link between their leadership development initiatives and their
overarching company goals.
• Candidates must provide evidence of the impact of their leadership programs on individual and
organizational growth.
• Affiliation: No requirement